Troglitazone: a possible modulator of ovarian steroidogenesis.
about
Decreased androgen levels and improved menstrual pattern after angiotensin II receptor antagonist telmisartan treatment in four hypertensive patients with polycystic ovary syndrome: case seriesThe origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome.Genetic variants in peroxisome proliferator-activated receptor gamma influence insulin resistance and testosterone levels in normal women, but not those with polycystic ovary syndromeEndocrinological actions of Unkei-to, a herbal medicine, and its clinical usefulness in anovulatory and/or infertile women.
P2860
Troglitazone: a possible modulator of ovarian steroidogenesis.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Troglitazone: a possible modulator of ovarian steroidogenesis.
@en
Troglitazone: a possible modulator of ovarian steroidogenesis.
@nl
type
label
Troglitazone: a possible modulator of ovarian steroidogenesis.
@en
Troglitazone: a possible modulator of ovarian steroidogenesis.
@nl
prefLabel
Troglitazone: a possible modulator of ovarian steroidogenesis.
@en
Troglitazone: a possible modulator of ovarian steroidogenesis.
@nl
P2093
P2860
P1476
Troglitazone: a possible modulator of ovarian steroidogenesis.
@en
P2093
Mohamed F M Mitwally
Robert F Casper
Selma F Witchel
P2860
P304
P356
10.1177/107155760200900308
P577
2002-05-01T00:00:00Z